Create issue ticket

348 Possible Causes for Luteinizing Hormone Low, Obesity

  • Hypogonadism

    Furthermore, obesity is a risk factor for hypogonadism and conversely hypogonadism may be a risk factor for obesity.[] hormone ( 9.4 mU/mL)], secondary (low total testosterone, low/normal luteinizing hormone), primary (low total testosterone, elevated luteinizing hormone) and compensated[] Men with hypogonadotropic hypogonadism, or HH, have abnormally low levels of luteinizing hormone, or LH, and follicle-stimulating hormone, or FSH, two hormones produced by[]

  • Polycystic Ovary Syndrome

    […] was 36.46% (70/192) of which 80.00% (56/70) was central obesity.[] hormone, follicle-stimulating hormone, total cholesterol, low-density lipoprotein C or insulin.[] hormone, follicle‐stimulating hormone, total cholesterol, low‐density lipoprotein C or insulin.[]

  • Hypogonadotropic Hypogonadism Type 22

    Risk factors for hypogonadism include type 2 diabetes, obesity, renal failure, HIV, hypertension, chronic obstructive pulmonary disease (COPD) and taking glucocorticoid (steroids[] His laboratory investigations showed low luteinizing hormone (LH), follicle stimulating hormone (FSH), and testosterone levels.[] Elevated follicle-stimulating hormone (FSH) or luteinizing hormone (LH) levels suggest an ovarian abnormality (hypergonadotropic hypogonadism).[]

  • Hypothyroidism

    SCFE usually occurs during puberty, with obesity a common risk factor.[] In addition to a low TSH, central hypothyroidism may be associated with deficiencies of other hormones, including: Growth hormone Adrenocorticotropic hormone, which stimulates[] […] explore the effect of a constant iodine intake through the diet in a postmenopausal woman with subclinical grade II hypothyroidism, who also had mild hypercholesterolemia and obesity[]

  • Klinefelter Syndrome

    Obesity is reported to have adverse effects on semen quality and the endocrine system.[] Endocrinological examination revealed a high growth hormone (GH) concentration, low testosterone concentration, and high follicle-stimulating hormone and luteinizing hormone[] The patient was a 21-year-old, tall and obese man. He had gynecomastia. The penis was short and bilateral testes were underdeveloped.[]

  • Cushing Syndrome

    In agreement with the known roles of cAMP signaling in the regulation of adiposity, patients with PPNAD were less obese than other patients with CS.[] The symptoms depend upon which hormone is involved. Reduction of sex hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH).[] CS is expected to have an incidence of 10 to 15 people per million; however, studies of patients with diabetes, obesity, hypertension, and osteoporosis found a high prevalence[]

  • Hypopituitarism

    Gastric bypass surgery has been reported to be an efficient treatment strategy for morbid hypothalamic obesity.[] Furthermore, insulin-like growth factor I was very low; follicle-stimulating hormone was normal; luteinizing hormone was low; total testosterone was very low, in the 30 ng[] Furthermore, laboratory tests showed low total triiodothyronine (T3), thyroxine (T4), free T3, free T4, luteinizing hormone, estradiol, follicle-stimulating hormone, and serum[]

  • Kallmann Syndrome

    Patients with this genetic form of KS have been reported to have a possible increased prevalence of obesity and sleep disorders, which may be related to the role of PROK2[] Serum luteinizing hormone levels were low or normal.[] A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998 Mar 26. 392(6674):398-401. [Medline].[]

  • Craniopharyngioma

    38% .01 Overweight 2% 5% .147 5% 11% .05 Grade 1 obesity 12% 9% .762 24% 23% .895 Grade 2 obesity 10% 11% .879 54% 28% .05 Mean time (95% CI) of follow-up for ERS: 103 months[] Reduction of sex hormones, luteinizing hormone (LH) and follicle-stimulating hormone (FSH).[] Hypothalamic obesity after treatment for craniopharyngioma is a well-recognized, severe problem.[]

  • Iatrogenic Cushing's Disease

    These effects include redistribution of fat resulting in moon face and centripetal obesity, glucocorticoid acne, buffalo hump, thinning of the skin, and purple striae.[] On investigation, testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were low [Table 1]. Serum cortisol ( [Table 1].[] Menstrual irregularities, amenorrhea, infertility, and decreased libido may occur in women related to inhibition of pulsatile secretion of luteinizing hormone (LH) and follicle-stimulating[]

Further symptoms

Similar symptoms